High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Poor Survival ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer

npj Precision Oncology ◽

10.1038/s41698-020-00128-1 ◽

2020 ◽

Vol 4 (1) ◽

Author(s):

Ke-Da Yu ◽

Xin Wang ◽

Wan-Kun Chen ◽

Lei Fan ◽

Miao Mo ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2016.04.004 ◽

2016 ◽

Vol 27 (2) ◽

pp. 160-161

Author(s):

R. Gopal

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Locoregional Recurrence ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy

Annals of Surgical Oncology ◽

10.1245/s10434-014-4321-2 ◽

2015 ◽

Vol 22 (8) ◽

pp. 2517-2525 ◽

Cited By ~ 20

Author(s):

Ryan M. Lanning ◽

Monica Morrow ◽

Nadeem Riaz ◽

Heather L. McArthur ◽

Chau Dang ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Locoregional Recurrence ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2–positive breast cancer

Cancer ◽

10.1002/cncr.32088 ◽

2019 ◽

Vol 125 (8) ◽

pp. 1213-1213

Author(s):

Carrie Printz

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Abstract P3-14-04: Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer

10.1158/1538-7445.sabcs19-p3-14-04 ◽

2020 ◽

Author(s):

Ke-Da Yu ◽

Zhi-Rui Zhou ◽

Zhi-Ming Shao

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Early Human ◽

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome

Clinical Breast Cancer ◽

10.1016/j.clbc.2011.03.012 ◽

2011 ◽

Vol 11 (3) ◽

pp. 153-160 ◽

Cited By ~ 14

Author(s):

Jonathan Krell ◽

Colin R. James ◽

Deep Shah ◽

Ondrej Gojis ◽

Adrian Lim ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Pattern Of Recurrence ◽

Adjuvant trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: Take-home points from the KATHERINE trial

The National Medical Journal of India ◽

10.4103/0970-258x.314006 ◽

2020 ◽

Vol 33 (3) ◽

pp. 158

Author(s):

Atul Batra ◽

Ilavarasi Vanidassane ◽

RamavathDevendra Naik ◽

Vinod Sharma ◽

Sachin Khurana

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04158505 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Real World ◽

Growth Factor Receptor ◽

Her2 Positive ◽

Epidermal Growth ◽

Looking Deep Into the Heterogeneity of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Can We Understand It Better?

Journal of Clinical Oncology ◽

10.1200/jco.2015.64.7495 ◽

2016 ◽

Vol 34 (6) ◽

pp. 521-523 ◽

Cited By ~ 4

Author(s):

Sherene Loi ◽

Peter Savas

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

The FASEB Journal ◽

10.1096/fj.202100070r ◽

2021 ◽

Vol 35 (7) ◽

Author(s):

Noor Mazin Abdulkareem ◽

Raksha Bhat ◽

Lanfang Qin ◽

Suhas Vasaikar ◽

Ambily Gopinathan ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Cellular Quiescence ◽

Epidermal Growth ◽